Schroder British Opportunities Ltd Overview
| Field | Detail |
|---|---|
| Legal name | Schroder British Opportunities Trust plc |
| Former names | None identified |
| Profiled entity | Schroder British Opportunities Trust plc (UK investment trust) |
| Founding / launch | Launched (IPO) 1 December 2020 (Schroders corporate-governance page: inception date 1 December 2020) |
| Incorporation jurisdiction | England and Wales; investment company under s.833 Companies Act 2006; approved investment trust under s.1158 Corporation Tax Act 2010 (Annual Report FY2026) |
| Registered office / correspondence address | 1 London Wall Place, London EC2Y 5AU, United Kingdom (Annual Report FY2026, AGM notice) |
| Exchange and ticker | London Stock Exchange, Main Market: SBO (shown on some data vendors as SBO.L) |
| ISIN | GB00BN7JZR28 |
| SEDOL | BN7JZR2 |
| LEI | 5493003UY8LIHFW6HM02 (from ESEF filing identifier) |
| CUSIP | Not applicable / not publicly disclosed |
| Share class | Ordinary shares of 1p |
| Shares in issue | 73,900,000 excluding treasury; 1,100,000 held in treasury (Annual Report FY2026) |
| Fiscal year end | 31 March (changed from 30 June with effect from 1 July 2021; the FY2022 period was nine months) |
| Employees | Nil. The company has no employees; all functions outsourced (Annual Report FY2026). 3-year trend: 0 / 0 / 0 |
| Directors | Four independent non-executive directors |
| AIFM / Investment Manager | Schroder Unit Trusts Limited (AIFM); portfolio management by Schroders Capital / Schroder Investment Management Limited |
| Portfolio Managers | Tim Creed and Peraveenan (Pav) Sriharan (Schroders Capital) |
| Company Secretary | Schroder Investment Management Limited |
| Depositary and custodian | J.P. Morgan Europe Limited (from 5 September 2025) |
| Auditor | Johnston Carmichael LLP (appointed January 2026 for the year ending 31 March 2026, following a competitive tender) |
| Ultimate parent of manager | Schroders plc, acquired by Nuveen (TIAA) with completion on 1 October 2026 |
| Market capitalisation (current) | c.£51.7m–£54.7m (73.9m shares × 70.00p–74.00p; most recent price observations 70.00p on 17 July 2026 and 74.00p per Stockopedia, retrieved October 2026, which states market cap of £54.69m) |
| Latest audited NAV | £79.2m / 107.24p per share at 31 March 2026 |
| Discount to NAV | 34.7% at 31 March 2026; c.36.4% on 20 May 2026 using daily NAV of 110.89p (AJ Bell) |
| Ongoing charges | 1.29% (FY2026); 1.50% (FY2025); 1.40% (FY2024) |
| Dividend | None; dividends paid only to the extent required to maintain investment-trust status |
| Gearing policy | Maximum 10% of NAV at drawdown; no borrowing disclosed |
| Website | www.schroders.com/sbo |
| Continuation mechanism | Managed wind-down resolution to be put to shareholders in Q1 2027, passing if any single vote is cast in favour (enhanced voting) |
The identification details supplied ("Schroder British Opportunities Ltd", Country: Austria, LSE, ticker SBO.L) partially match. The listed entity behind ticker SBO on the London Stock Exchange is Schroder British Opportunities Trust plc, a UK public limited company and approved UK investment trust. It is not an Austrian entity and is a "plc", not a "Ltd". The "Austria" tag in the source list appears to be a data error. One portfolio holding (Cera Care) is held via a Luxembourg vehicle and the liquidity fund is Luxembourg-domiciled, but the issuer itself is UK-domiciled.
Schroder British Opportunities Trust plc is a sub-£100m London-listed investment trust that offers retail and institutional investors access to minority stakes in established, EBITDA-positive, predominantly UK private companies, sourced through Schroders Capital's European private-equity network of more than 100 specialist general-partner relationships. Launched in December 2020 as a hybrid public/private UK growth vehicle, it abandoned its quoted-equity sleeve in 2025 after that sleeve detracted from returns, and since 31 May 2026 has been a pure private-equity portfolio of twelve holdings, heavily tilted towards vertical software, insurance-related technology and tech-enabled services (Expana, Arrive, Pirum, CFC Underwriting, Cera Care, CSL, Acturis, Culligan, JMG, Rapyd). Portfolio companies are growing sales and EBITDA in the mid-teens with c.37% average EBITDA margins, yet the shares trade at a persistent discount of roughly 35% to NAV. The decisive near-term event is a shareholder vote in Q1 2027 that is structurally biased towards an orderly multi-year managed wind-down.
The company's own description (paraphrased from the FY2026 Annual Report)
The company describes its purpose as giving all investors access to high-quality, predominantly UK-based private companies focused on sustainable growth, with the Board prioritising long-term capital growth over dividend income. Its formal investment objective, adopted at the General Meeting of 9 September 2025, is to deliver long-term total returns over the life of the company by investing in a diversified portfolio of private equity investments in predominantly UK companies. "UK Companies" is defined broadly to include businesses incorporated, headquartered or principally active in the UK, and overseas-headquartered businesses deriving a significant share of revenues or profits from the UK.
The company carries on business as an externally managed investment trust. It has outsourced all operations: the Board sets strategy and oversees service providers; the Investment Manager implements the investment process, manages risk, values unquoted holdings (subject to Board Valuations Committee oversight) and markets the shares.
Investment policy parameters (FY2026 Annual Report)
| Parameter | Policy |
|---|---|
| Eligible instruments | (a) unlisted shares, LP interests and equivalents; (b) warrants, options, convertibles and other rights over (a); (c) preference shares; (d) debt instruments including loan stock, PIK and shareholder loans. Focus expected on (a) and (b) |
| Target company size | Equity value c.£50m to £2bn at time of initial investment |
| Single-company limit | Max 15% of NAV per investee company (at commitment) |
| Non-UK limit | Max 20% of NAV in companies that are not UK Companies |
| Control | No controlling stakes; max 20% of enterprise value of any investee |
| Listed funds | Max 10% of gross assets in listed closed-ended funds (15% absolute cap for investment companies on the Official List) |
| Gearing | Max 10% of NAV at drawdown |
| Derivatives | Permitted for investment, efficient portfolio management and currency hedging; non-sterling exposure normally unhedged |
| Cash | No limit; may hold significant cash and money market funds |
| Look-through | Restrictions applied on a look-through basis for SPVs |
Business and "revenue" model
| Revenue/return source | Characterisation | Materiality |
|---|---|---|
| Unrealised gains/losses on unquoted holdings | Quarterly fair-value revaluations by Schroders Capital using EBITDA/gross-profit multiples and recent transaction prices | Dominant driver of NAV |
| Realised gains and distributions | E.g. £1.2m distribution from CFC Underwriting (FY2026); £2.4m Waterlogic distribution (FY2023) | Episodic |
| Quoted equity gains/losses | Daily mark-to-market; fully exited by 31 May 2026 | Historical only |
| Money-market and interest income | Schroder Special Situations – Sterling Liquidity Plus Fund (£8.6m at 31 March 2026) | Small |
| Dividend income | Historically from quoted holdings | Now negligible |
As an investment trust, SBO's economic model is the generation of capital gains (and occasional distributions) from its portfolio, net of management fees, performance fees and operating costs. Its accounting "revenue" consists of investment income (dividends from quoted holdings historically, interest and money-market income); the company has consistently reported a net revenue loss per share (for example, –0.77p for the nine months to 31 March 2022 and –0.86p for FY2023), reflecting the low-yielding, capital-growth nature of the portfolio. Total return is overwhelmingly driven by capital movements in unquoted valuations.
Product vs service vs subscription vs licensing mix: not applicable. The trust's look-through exposure is, however, weighted to recurring-revenue software and subscription/data businesses (Expana, Pirum, Acturis, Arrive) and tech-enabled services (Cera, CSL, Rapyd, JMG, CFC).
Value-chain position and fee structure
| Fee element | Terms (as disclosed) |
|---|---|
| Management fee | Calculated on quarterly cum-income NAV (platform summary of Annual Report terms) |
| Performance fee | 15% of the amount by which the Private Equity Portfolio Total Return over a calculation period exceeds a 10% p.a. hurdle (Hargreaves Lansdown summary of AIFM agreement); terms amended during FY2026 per the Section 172 report |
| Performance fee history | £1.67m accrued at 31 March 2024 and 31 March 2025, paid during FY2026; no performance fee accrued in FY2026 |
SBO sits as a listed minority co-investor alongside lead private-equity sponsors. Most holdings are accessed through intermediary vehicles managed by third-party GPs (Synova, Bowmark, Vitruvian, Astorg, EPIC/EQT-linked fund, Target Global, ECI, ILC, Agilitas), meaning SBO is typically a co-investor rather than the lead sponsor.
Customer types and end-markets
| End-market (look-through) | Holdings |
|---|---|
| Vertical software / data | Expana (food commodity pricing), Pirum (securities-finance post-trade), Acturis (insurance SaaS), Arrive (parking/mobility platform) |
| Specialist insurance | CFC Underwriting |
| Insurance broking (financial services) | JMG Group |
| Health care technology / home care | Cera Care |
| IT services / IoT connectivity | CSL |
| Payments infrastructure | Rapyd Financial Network |
| Water treatment / consumer services | Culligan |
| HR technology / workforce solutions | HeadFirst Global |
| Education and training | Learning Curve Group |
The trust's "customers" are its shareholders: UK retail investors via platforms (the shares are ISA/SIPP-eligible), wealth managers and institutional holders. Look-through end-markets are summarised below (FY2026 Annual Report sector classifications).
Independent characterisation
SBO is best understood as a small, concentrated, closed-end feeder into Schroders Capital's UK/European growth and small/mid-buyout co-investment programme, wrapped in a listed structure with a built-in exit date. Its distinguishing features versus larger listed private-equity trusts are: (i) direct/co-investment exposure rather than fund-of-funds; (ii) a UK mandate; (iii) a very small asset base (c.£79m NAV), which inflates the ongoing-charge ratio and limits liquidity; and (iv) a governance structure that makes a managed wind-down the default outcome in 2027. The 2025 strategy pivot effectively converted it from a "public-private growth fund" into a run-off-ready private-equity portfolio.
Strategy
Stated strategy (themes from FY2026 Annual Report)
The Board and Manager describe the strategy around four themes: (1) concentration on private equity in predominantly UK companies, the part of the portfolio that historically performed best; (2) disciplined deployment, explicitly not compromising quality to accelerate the transition; (3) robust, Board-challenged valuations; and (4) long-term value creation and eventual realisations, with the fixed-life structure as the principal discount remedy. The Manager targets growth capital and small-to-mid buyouts, avoiding venture and large/mega-buyout segments where it sees heightened valuation risk, and looks for a "Growth Gap" between company fundamentals and market expectations.
Strategic initiatives in the last 24 months
| Date | Initiative | Detail / target |
|---|---|---|
| 17 Mar 2025 | Proposed all-private-equity policy | Rationale: private holdings returned 1.5x cost since IPO while public holdings detracted |
| 17 Mar 2025 | Accelerated continuation vote | Bring winding-up resolution forward from by 31 May 2028 to Q1 2027 |
| 29 Jul 2025 | Circular and General Meeting | Formal proposals; shareholder consultation conducted |
| 9 Sep 2025 | Policy and Articles approved | Strategy implemented |
| FY2026 | Quoted sleeve run-off | 13 quoted positions exited for £10.0m; remainder exited by 31 May 2026 |
| FY2026 | New private investments | JMG (£4.8m) and CSL (£5.7m) |
| Sep 2025 | Depositary re-tender | Cost savings |
| Jan 2026 | Audit re-tender | Expected significant cost savings |
| FY2026 | Buyback policy | Board chose to retain capital for deployment rather than buy back shares |
| Ongoing | AI monitoring | Manager assessing AI opportunities and risks across portfolio |
Medium-term targets and guidance
There is no formal financial guidance. The original 10% p.a. NAV total-return target (once fully deployed) appeared in the FY2022 and FY2023 reports; it is not restated in the FY2026 report under the new policy. The performance fee hurdle remains 10% p.a. on the private equity portfolio. The Board intends to deploy some cash in the coming months while retaining liquidity for uncalled commitments and costs. The Manager notes that most private holdings typically need a holding period of at least five years to realise their full value, which frames the likely length of any wind-down.
ESG commitments
The company states it is not a sustainable product under FCA rules; ESG factors are integrated into the Manager's process but no specific sustainability outcomes are targeted.
Products & Services
SBO has one "product": its listed ordinary share. The relevant catalogue is therefore the portfolio of underlying holdings, which is presented company by company below (all data from Annual Report FY2026 unless stated; fair values in GBP thousands).
The listed share
| Attribute | Detail |
|---|---|
| Instrument | Ordinary shares of 1p, LSE Main Market |
| Eligibility | ISA, Lifetime ISA, JISA, SIPP (AJ Bell, Hargreaves Lansdown) |
| Pricing | Market-priced; trades at a discount to NAV |
| NAV publication | Daily NAV (quoted holdings revalued daily; unquoted quarterly with a lag); quarterly NAV statements |
| Charges | OCR 1.29% (FY2026) plus performance fee above 10% hurdle |
| Income | No dividend |
Private equity holdings (full portfolio at 31 March 2026)
| Holding | Vehicle / lead GP | Country | Sector | FV 31/03/2025 (GBP K) | FV 31/03/2026 (GBP K) | % total investments FY2026 |
|---|---|---|---|---|---|---|
| Expana (formerly Mintec) | Synova Merlin LP | UK | Software | 10,136 | 8,623 | 10.8 |
| Arrive (formerly EasyPark) | Purple Garden Invest (D) AB | Sweden | Software | 6,506 | 8,040 | 10.0 |
| Pirum Systems | Bowmark Investment Partnership LP | UK | Software | 7,466 | 7,322 | 9.1 |
| CFC Underwriting | Vitruvian Investment Partnership | UK | Insurance | 6,245 | 6,727 | 8.4 |
| Cera Care | Direct (Cera EHP S.à r.l.) | UK | Health Care Technology | 7,234 | 6,184 | 7.7 |
| CSL | ECI 12 Special Purpose LP | UK | IT Services | 0 | 5,943 | 7.4 |
| Acturis | Astorg co-invest vehicle | UK | Software | 4,351 | 5,777 | 7.2 |
| Culligan (formerly Waterlogic) | EPIC-1b Fund | UK (per report) | Diversified Consumer Services | 5,390 | 5,623 | 7.0 |
| JMG Group | Synova Jove LP | UK | Financial Services | 0 | 4,723 | 6.0 |
| Rapyd Financial Network | Target Global Fund | UK (per report) | IT Services | 4,339 | 4,042 | 5.0 |
| HeadFirst Global | ILC HF 2 C.V. Fund | Netherlands | Human Resource Technology | — | 2,574 | 3.3 |
| Learning Curve Group | Agilitas Boyd 2020 Co-invest Fund | UK | Diversified Consumer Services | — | 882 | 1.1 |
Note: the Annual Report names the Acturis vehicle inconsistently ("Astorg VIII Co-Invest Acturis" in the top-10 notes and "Astorg VII Co-Invest Lithium Fund" in the portfolio list); both are recorded here as a discrepancy.
Company-by-company profiles
Expana (formerly Mintec) — Largest holding. Provider of food and agricultural commodity price assessments, cost models and analytics delivered through a SaaS platform (Mintec Analytics) to large food and manufacturing brands for procurement. Brand family includes Urner Barry, Mintec, Feedinfo, Tropical Research Services and Stratégie Grains. Key 2025–26 developments: price forecasts for Urner Barry protein benchmarks (May 2025); unified food market-intelligence platform with AI-enhanced cost models (October 2025); sixth consecutive IOSCO assurance review covering 123 price assessments (January 2026); appointment of Julie Harris as CEO. FY2026 contribution –1.9% of NAV due to software/data multiple compression. Pricing model: subscription (not separately disclosed).
Arrive (formerly EasyPark) — Swedish-headquartered parking, EV-charging and urban mobility technology group. In June 2025 the group rebranded under the Arrive parent brand, uniting EasyPark, Flowbird, ParkMobile, Parkopedia, RingGo, Yellowbrick, YourParkingSpace and others, describing operations across more than 90 countries and 20,000 cities. Announced a Google Cloud partnership for AI-driven automation; expanded in Italy to over 1,000 municipalities (88% of paid parking zones, November 2025). FY2026 contribution +1.9% of NAV. Non-UK holding (Sweden) counts towards the 20% non-UK limit.
Pirum Systems — UK provider of post-trade automation and collateral-management technology for global securities-lending and financing markets, acting as a secure processing hub between market participants. TradeConnect, its pre-trade connectivity platform, facilitated its first live trades (including Citi) in November 2025, marking expansion from post-trade into pre-trade. FY2026 value broadly flat (£7.47m to £7.32m).
CFC Underwriting — Technology-driven specialist insurance business (cyber, technology, transaction liability, specialty lines), more than 20 years old. Launched Cyber Proactive Response for businesses up to £250m revenue (April 2025) and extended it into digital health, fintech and technology policies (May 2025); appointed a new CEO for CFC USA (December 2025). Largest positive contributor in FY2026 (+1.9% of NAV); paid SBO a £1.2m distribution following a capital restructuring.
Cera Care — Self-described as Europe's largest digital-first home healthcare provider, delivering care, nursing, telehealth and repeat medications at home using an AI-led platform. Third-party analysis (Faculty, July 2025) credited Cera with over £1bn of NHS and government savings; 100 millionth visit (November 2025); in June 2026 reported ARR up c.$200m year on year (+56%), with over 33 million home visits annually. Despite this, FY2026 contribution was –1.4% of NAV owing to multiple moderation. Held directly via a Luxembourg entity.
CSL — New investment (£5.7m paid in, FY2026). European leader in mission-critical connectivity and IoT, providing resilient managed connectivity (including patented rSIM technology) for healthcare, security, critical infrastructure and utilities. Launched rSIM in Canada with Rogers Business (April 2025); named Vodafone Business Alliance Partner of the Year (May 2025). Valued at recent transaction price at year end (one of the most recent acquisitions).
Acturis — UK insurance SaaS founded in 2000, providing cloud workflow and distribution software to brokers, insurers and MGAs. Aviva became first insurer on Unify, Acturis' AI/data placement tool (June 2025); added Markel and Beech Underwriting products (2025–March 2026). FY2026 contribution +1.8% of NAV; value up from £4.35m to £5.78m.
Culligan (formerly Waterlogic) — Global water-treatment brand founded in 1936 in Illinois, spanning household filtration to industrial solutions. Launched "Culligan with ZeroWater Technology" pitchers (May 2025). SBO's original holding was Waterlogic, which merged into Culligan. Small positive contributor in FY2026.
JMG Group — New investment (£4.8m, FY2026). One of the UK's fastest-growing independent insurance brokers, executing a buy-and-build strategy (20 acquisitions in the prior year per February 2025 update); acquired Boston, Hayton and Gateway brokers (September 2025) and Taveo Group's broking business (October 2025).
Rapyd Financial Network — Global fintech-as-a-service and payments platform aggregating 900+ payment methods in 100+ countries. Completed acquisition of PayU's Global Payment Organisation (LatAm and Africa) in March 2025. Held via Target Global Fund. Value declined modestly (£4.34m to £4.04m).
HeadFirst Global — Netherlands-headquartered STEM talent and managed-service provider formed by combining HeadFirst Group and Impellam Group; reported 2024 gross invoice value of €2.64bn. Appointed Edzard Overbeek as Group CEO (February 2025). Largest detractor in FY2026 (–3.2% of NAV; £1.5m company-event write-down).
Learning Curve Group — UK further-education and training specialist founded 2004; opened Sunderland Construction Academy (September 2025). Valuation cut by £1.0m in FY2026 due to reduced visibility; now 1.1% of investments.
Former quoted holdings (exited by 31 May 2026)
| Quoted holding at 31 March 2026 | Sector | FV (GBP K) |
|---|---|---|
| Watches of Switzerland Group | Specialty Retail | 1,700 |
| SSP Group | Hotels, Restaurants & Leisure | 967 |
| On the Beach Group | Hotels, Restaurants & Leisure | 888 |
| Trustpilot | Interactive Media & Services | 688 |
| Bytes Technology | Software | 347 |
| Victorian Plumbing | Specialty Retail | 295 |
| Warpaint London | Personal Care Products | 174 |
Earlier quoted names referenced in filings include Volution, OSB, Blue Prism, National Express, GB Group, Ascential and Genuit.
Liquidity holding
| Holding | Domicile | FV 31/03/2026 (GBP K) | % of investments |
|---|---|---|---|
| Schroder Special Situations – Sterling Liquidity Plus Fund | Luxembourg SICAV | 8,582 | 10.7 |
Financial Narrative
Basis: FY2022 = nine months to 31 March 2022; FY2023–FY2026 = years to 31 March. FY2021 (period from launch on 1 December 2020 to 30 June 2021) is shown separately. Currency GBP. Operating-company metrics such as gross profit, operating income, EBITDA, capex, working capital, ROIC, interest coverage and cash conversion cycle are not applicable to an investment trust and are marked as such.
Core NAV and share-price metrics
Sources: Annual Reports FY2022, FY2023, FY2025, FY2026; AJ Bell report of FY2023 results (net assets £79.3m vs £78.1m); RNS 19 September 2024 (31 March 2024 net assets £81.3m). Shares in issue FY2022 derived (75.0m before 1.1m FY2023 buyback).
FY2021 reference (period to 30 June 2021): NAV per share 108.44p; share price 105.00p; discount 3.2%; net revenue loss per share –0.58p; implied net assets c.£81.3m (derived, 75.0m shares).
"Income statement" proxy
Sources: AJ Bell coverage of FY2023 results (pre-tax profit £2.0m vs loss of £3.2m); Annual Reports FY2022/FY2023 (net revenue loss per share). FY2023 change in net assets includes the effect of the 1.1m-share buyback, so it is not a pure return figure. FY2024–FY2026 total return derived from NAV movements with unchanged share count.
Margins (gross, operating, EBITDA, net): not applicable. Revenue CAGR: not applicable. NAV per share CAGR FY2022–FY2026: c.0.7% p.a. (derived: 104.14p to 107.24p over four years). Since-IPO NAV total return: +9.4% (to 31 March 2026, Annual Report FY2026), roughly 1.7% p.a. over c.5.3 years (derived), far below the original 10% p.a. NAV total-return target.
Balance sheet proxy
FY2025 total investments derived as unquoted + quoted + money market funds (58.6 + 15.4 + 8.2). FY2023 cash is "available cash for future investments" (RNS 6 July 2023). No borrowings have been disclosed in any period reviewed. Working capital is not a meaningful metric; "other net liabilities" were c.£1.3m–£1.4m in FY2025–FY2026 (including the accrued performance fee in FY2025).
Cash flow proxy: notes and sources
Sources: Annual Report FY2026 (investments, realisations, distribution); QuotedData (FY2023 Waterlogic distribution); Annual Report FY2025 (performance fee to be paid in FY2026).
Ratios
Price-to-NAV derived from discount. Net cash % derived from net cash ÷ net assets. ROA, ROIC, current ratio, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle: not applicable (ungeared investment company with no operating business).
Commentary on trends, inflections and drivers
NAV has essentially stood still for five years. NAV per share moved from 108.44p at June 2021 to 107.24p at March 2026; the since-IPO NAV total return of 9.4% equates to under 2% a year. The drivers have changed over time. In FY2022–FY2023 the quoted UK small/mid-cap sleeve (Victorian Plumbing, Trustpilot, National Express, GB Group, Ascential, Genuit) detracted heavily while the private sleeve contributed positively (private holdings added c.10% to NAV in FY2023 while public holdings subtracted 5.9%). In FY2025 private equity added only £0.5m (0.62% of NAV) and peer-multiple adjustments cost c.3% of NAV (Kepler, July 2025). In FY2026 the drag shifted to the private book itself: multiple compression, especially among the seven technology holdings, linked by the Chair to market anxiety about AI "winners and losers", overwhelmed 16.3% average sales and EBITDA growth.
The share price has decoupled from NAV. The discount widened from 3.2% (June 2021) to 19.3% (March 2022) and 36.2% (March 2023), briefly narrowed to 27.8% (March 2024) and widened again to 37.1% (March 2025) before easing to 31.8% (September 2025) and 34.7% (March 2026). The share price has fallen roughly 30% since IPO on a total-return basis. The FY2024 share-price TR of +16.1% and the H1 FY2026 TR of +7.9% were both discount-driven rather than NAV-driven.
Cost ratios are elevated by scale. An OCR of 1.29%–1.50% on a c.£80m vehicle is high relative to the trust's NAV returns; the reduction to 1.29% in FY2026 reflects depositary and audit re-tenders, which the Board explicitly framed as cost-saving measures.
Inflection point: The decisive inflection is strategic, not financial. With quoted holdings gone, NAV will now move in quarterly steps tied entirely to private valuations. The December 2025 quarter (+1.27% to 111.3p) and the post-year-end daily NAV of 110.89p (20 May 2026, AJ Bell) suggest some of the Q4 FY2026 multiple compression reversed, consistent with the Chair's outlook comments.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Segment Assets & Liabilities
| Segment (GBP Mn) | FY2025 | FY2026 |
|---|---|---|
Unquoted investments | 58.6 | 66.5 |
Quoted investments | 15.4 | 5.0 |
Money market funds | 8.2 | 8.6 |
Cash and cash equivalents | 0.8 | 0.5 |
Other net assets/(liabilities) | -1.3 | -1.4 |
NAV | 81.7 | 79.2 |
Segment Assets & Liabilities (%) and Revenue by Segment (%)
| Segment (% of NAV) | FY2022 | FY2025 | FY2026 |
|---|---|---|---|
Private equity (unquoted) | 35 | 71.7 | 84 |
Public equity (quoted) | 48 | 18.9 | 6 |
Cash and liquidity | 17 | 9.4 | 10.8 |
Components
| Component | Contribution to NAV change (%) | GBP Mn fair value movement |
|---|---|---|
Unquoted holdings | -1.9 | -1.6 |
Quoted holdings | -0.5 | -0.4 |
Money market funds | 0.4 | 0.3 |
Costs and other movements | -1.0 | -0.8 |
Total | -3.0 | -2.5 |
Bridge Item Details
| Bridge item | GBP Mn |
|---|---|
Opening value 31 March 2025 | 58.6 |
Paid-in (mainly CSL £5.7m and JMG £4.8m) | 10.7 |
Distributions (CFC Underwriting) | -1.2 |
Company events (Learning Curve and HeadFirst) | -2.5 |
Valuation multiple compression | -5.8 |
Performance metric (earnings growth) | 8.2 |
Net debt, FX and other | -1.6 |
Closing value 31 March 2026 | 66.5 |
Segment Revenue
| Holdings count | FY2024 Q1 (Jun 2024) | FY2025 (Mar 2025) | H1 FY2026 (Sep 2025) | Q3 FY2026 (Dec 2025) | FY2026 (Mar 2026) | May 2026 |
|---|---|---|---|---|---|---|
Private | 10 | 10 | 10 | 12 | 12 | 12 |
Public | 21 | 20 | 14 | 7 | 7 | 0 |
Key Financials and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
NAV per share (pence) | 104.14 | 107.32 | 110.05 | 110.54 | 107.24 |
Share price at period end (pence) | 84.00 | 68.50 | 79.50 | 69.50 | 70.00 |
Discount to NAV (%) | 19.3 | 36.2 | 27.8 | 37.1 | 34.7 |
NAV per share total return (%) | -4.0 | 3.1 | 2.5 | 0.5 | -3.0 |
Share price total return (%) | -20.0 | -18.5 | 16.1 | -12.6 | 0.7 |
Net assets (GBP Mn) | 78.1 | 79.3 | 81.3 | 81.7 | 79.2 |
Shares in issue ex-treasury (m) | 75.0 | 73.9 | 73.9 | 73.9 | 73.9 |
Ongoing charges ratio (%) | — | — | 1.40 | 1.50 | 1.29 |
Income Statement
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Profit/(loss) before tax (GBP Mn) | -3.2 | 2.0 | — | — | — |
Total return / change in net assets (GBP Mn, derived) | — | 1.2 | 2.0 | 0.4 | -2.5 |
NAV per share change (pence, derived) | -4.30 | 3.18 | 2.73 | 0.49 | -3.30 |
Net revenue return per share (pence) | -0.77 | -0.86 | — | — | — |
Dividends per share (pence) | 0 | 0 | 0 | 0 | 0 |
Financial Analysis
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total investments incl. liquidity fund | — | — | — | 82.2 | 80.1 |
Unquoted investments | — | — | — | 58.6 | 66.5 |
Quoted investments | — | — | — | 15.4 | 5.0 |
Net cash incl. liquidity fund | — | 7.8 | 11.585 | 8.992 | 9.055 |
Total debt | 0 | 0 | 0 | 0 | 0 |
Net debt | 0 | 0 | 0 | 0 | 0 |
Equity (net assets) | 78.1 | 79.3 | 81.3 | 81.7 | 79.2 |
Goodwill and intangibles — not applicable | 0 | 0 | 0 | 0 | 0 |
Financial Analysis — Purchases of private equity
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Purchases of private equity (paid-in) | — | — | — | — | 10.7 |
Realisations of quoted holdings | — | — | — | — | 10.0 |
Distributions from unquoted holdings | — | 2.4 | — | — | 1.2 |
Capex — not applicable | 0 | 0 | 0 | 0 | 0 |
Dividends paid | 0 | 0 | 0 | 0 | 0 |
Share buybacks (shares, m) | 0 | 1.1 | 0 | 0 | 0 |
Performance fee paid | — | — | — | — | 1.67 |
Margin Analysis (%) and Valuation Multiples (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE proxy = NAV total return (%) | -4.0 | 3.1 | 2.5 | 0.5 | -3.0 |
Price to NAV (x) | 0.81 | 0.64 | 0.72 | 0.63 | 0.65 |
Debt to equity (x) | 0 | 0 | 0 | 0 | 0 |
Net cash as % of NAV | — | 9.8 | 14.2 | 11.0 | 11.4 |
Ongoing charges (%) | — | — | 1.40 | 1.50 | 1.29 |
Country (GBP Mn) Overview
| Country (GBP Mn) | FY2026 |
|---|---|
United Kingdom (equities) | 60.9 |
Sweden (Arrive) | 8.0 |
Netherlands (HeadFirst) | 2.6 |
Luxembourg (liquidity fund) | 8.6 |
Total investments | 80.1 |
Sector Details
| Sector (GBP Mn) | FY2026 |
|---|---|
Software | 30.1 |
IT Services | 10.0 |
Insurance | 6.7 |
Diversified Consumer Services | 6.5 |
Health Care Technology | 6.2 |
Financial Services | 4.7 |
Human Resource Technology | 2.6 |
Specialty Retail | 2.0 |
Hotels, Restaurants & Leisure | 1.9 |
Interactive Media & Services | 0.7 |
Personal Care Products | 0.2 |
Total equities | 71.5 |
Market Valuation and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Share price at year end (pence) | 84.00 | 68.50 | 79.50 | 69.50 | 70.00 |
Share price total return (%) | -20.0 | -18.5 | 16.1 | -12.6 | 0.7 |
Discount to NAV (%) | 19.3 | 36.2 | 27.8 | 37.1 | 34.7 |
Market capitalisation at year end (GBP Mn, derived) | 63.0 | 50.6 | 58.8 | 51.4 | 51.7 |
Horizon | Share price performance | — | — | — | — |
1-year | Approximately –5% to +4% depending on data vendor and date (StockAnalysis: –5.48% 1-year as of July 2026; Stockopedia: +3.5% over 365 days at a 74.00p price) | — | — | — | — |
3-year | From 68.50p (31 March 2023) to 70.00p (31 March 2026): c.+2% | — | — | — | — |
5-year / since IPO | Share price total return –30% since IPO at 100p (Annual Report FY2026) | — | — | — | — |
52-week range | 62.00p–77.00p (AJ Bell, May 2026); HL shows a 59.00p year low as of April 2026 | — | — | — | — |
Valuation Snapshot
| Multiple | Value | Comment |
|---|---|---|
Price/NAV (P/B equivalent) | c.0.65x (March 2026); c.0.64x (May 2026) | Derived from discount |
Capital Markets
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Dividend per share (pence) | 0 | 0 | 0 | 0 | 0 |
Analyst Conclusions
Management outlook (FY2026 Annual Report)
The Board is "cautiously optimistic". It notes that some of the multiple compression in Q4 FY2026 had reversed after year end and that the portfolio has been entirely private equity since 31 May 2026. The Manager sees a robust pipeline and intends to deploy some cash while retaining reserves for uncalled commitments. Both expect a maturing portfolio to support realisations and eventual capital returns. The Board does not expect the Nuveen–Schroders combination to affect the company.
Consensus expectations
No consensus forecasts exist.
Bull case
-
Operations are outrunning valuations. Mid-teens sales and EBITDA growth, 37% margins and all holdings EBITDA-positive mean NAV should compound once multiples stabilise. Earnings growth alone added £8.2m in FY2026.
-
Discount capture. A managed wind-down converts a c.35% discount into realised NAV over time. Even after costs and a multi-year timeline, buying at roughly 0.65x NAV offers asymmetric upside if exits occur near carrying values. The 1.5x cost multiple to date and distributions from CFC and Waterlogic lend support.
-
Quality exit candidates. Arrive, CFC, Acturis, Pirum and Cera are scaled, sponsor-backed assets in active M&A sectors, and lower UK rates improve the exit environment.
Bear case
-
Long, uncertain run-off. The Manager's own guidance implies a holding period of at least five years. A wind-down from 2027 could therefore stretch to 2030 or beyond, eroding the time value of the discount, while fixed costs weigh more heavily as NAV shrinks.
-
Valuation risk in software. About 45% of equity value sits in software, and AI-driven de-rating may prove structural rather than temporary. Repeated write-downs (HeadFirst, Learning Curve, Expana) show that carrying values are not guaranteed.
-
Track record. NAV is roughly flat since 2021, the original 10% p.a. target has been missed by a wide margin, and the share price is 30% below IPO. Shareholders may doubt that exits will crystallise current marks.
Key catalysts and monitorables (next 12 months)
| Catalyst | Expected timing |
|---|---|
| Quarterly NAV for 30 June 2026 and 30 September 2026 | Q4 2026 |
| Half-year report to 30 September 2026 | December 2026 |
| Board consultation with major shareholders on alternatives | Late 2026 / early 2027 |
| Managed wind-down resolution | Q1 2027 |
| Any realisation of a top-10 holding (e.g. Arrive, CFC, Pirum, Acturis) | Ongoing |
| Capital deployment from cash reserves | Coming months per Board |
| Post-Nuveen integration effects on the Schroders Capital team | 12–18 months from 1 October 2026 |
| Software multiple trends and AI sentiment | Ongoing |
Analyst verdict
Schroder British Opportunities Trust is no longer a growth fund; it is a special situation. Its five-year record is poor at both NAV and share-price levels, largely because the quoted UK small/mid-cap sleeve detracted and, more recently, because public software multiples compressed. The Board responded decisively in 2025, eliminating the public sleeve, cutting service costs and bringing forward a continuation vote with enhanced voting rights that make a managed wind-down the default outcome in Q1 2027.
The investment case now rests almost entirely on two variables: whether the twelve private holdings can be realised near their £66.5m carrying value, and how long that takes. Operating evidence is encouraging. Average revenue and EBITDA growth is around 16%, margins exceed 37%, every holding is profitable, and several assets (Arrive, CFC, Acturis, Cera) show strong momentum. Against this, roughly half the portfolio is exposed to a software valuation regime that has turned hostile. Two holdings have already suffered company-specific write-downs, and the Manager's own five-year holding-period guidance implies a long tail. Most positions are minority stakes in GP-controlled vehicles, so SBO does not control exit timing.
At around 0.65x NAV, the market is pricing in a substantial haircut for time, costs and valuation scepticism. For patient investors comfortable with illiquidity, the risk/reward appears moderately favourable if the wind-down proceeds and exits come close to marks: the gross discount implies about 50% upside to NAV, which shrinks considerably once a multi-year timeline and run-off costs are applied. For investors needing liquidity or certainty, the shares are unattractive. The key datapoints to watch are the outcome of the Board's shareholder consultation, the first realisations among top-ten holdings, and whether post-year-end NAV recovery persists through the 2026 quarterly valuations. Overall stance: special-situation, discount-capture hold, with valuation and timing risk explicitly acknowledged.
End of dossier. Figures are taken from the cited company filings and announcements.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Role | Tenure / notes |
|---|---|---|
Tim Creed | Portfolio Manager, Schroders Capital (private equity) | Named on the FY2026 Investment Manager's Report |
Peraveenan (Pav) Sriharan | Portfolio Manager, Schroders Capital | Presents results videos for FY2025 H1 and FY2026 |
Uzo Ekwue | Former Co-Portfolio Manager (public equities) | Stepped down March 2025 |
Board of Directors
| Director | Role | Appointed | Background (summarised) | Annual fee (GBP) | Shares held (31/03/2026) |
|---|---|---|---|---|---|
Justin Ward | Chair of the Board; Chair of Nomination and Remuneration Committee | Jul 2024 (Chair from FY2025) | Chartered Accountant and private-equity specialist; formerly at CVC Capital Partners and partner at Hermes Private Equity and Bridgepoint Development Capital; angel investor; NED at Gresham House Income & Growth VCT and Hargreave Hale AIM VCT | 46,250 | 40,691 |
Diana Dyer Bartlett | Senior Independent Director; Chair of Audit and Risk Committee | Nov 2020 | Chartered Accountant (Deloitte Haskins & Sells); investment banking at Hill Samuel; finance director roles; former company secretary of Tullett Prebon and Collins Stewart Tullett; former Chair of Smithson Investment Trust; Audit Chair at Mid Wynd and Mobius Investment Trust | 40,500 | 73,832 |
Tim Jenkinson | Independent NED; Chair of Valuations Committee | Nov 2020 | Professor of Finance, Saïd Business School, Oxford; Director of the Oxford Private Equity Institute; partner at Oxera | 40,500 | 6,609 |
Jemma Bruton | Independent NED; Chair of Management Engagement Committee | Jul 2024 | Cambridge economics, INSEAD MBA; formerly Executive Director, Leveraged Finance at Goldman Sachs; co-managing director at Salica Investments Advisory | 37,500 | 10,000 |
Board & Management Changes
| Date | Change |
|---|---|
Jul 2024 | Justin Ward and Jemma Bruton join the Board |
FY2025 | Justin Ward becomes Chair, succeeding Neil England |
Mar 2025 | Uzo Ekwue steps down as Co-Portfolio Manager |
Sep 2025 | New Articles of Association adopted |
Sep 2025 | Depositary changed to J.P. Morgan Europe |
FY2026 | Amendments to performance-fee terms within AIFM agreement approved by Board |
Jan 2026 | Auditor changed to Johnston Carmichael LLP |
1 Oct 2026 | Manager's parent Schroders acquired by Nuveen; Board expects no impact on the company |
Competitive Landscape
Key Competitors
| Peer | Ticker | Model | Relative positioning vs SBO |
|---|---|---|---|
HgCapital Trust | HGT | Concentrated buyout exposure to European software via Hg funds | Much larger; same software thesis; historically stronger NAV record |
Oakley Capital Investments | OCI | Funds plus co-investments, European mid-market | Larger; consumer, education, tech, business services |
ICG Enterprise Trust | ICGT | Diversified PE, primaries/secondaries/direct | Larger, more diversified, pays dividend |
Pantheon International | PIN | Global fund-of-funds and co-investments | Much larger, global |
HarbourVest Global Private Equity | HVPE | Global fund-of-funds | Much larger, global |
Patria Private Equity Trust | PPET | European mid-market funds and co-investments | Larger; similar European mid-market focus |
The Investment Company Literacy Capital | BOOK | UK SME buyouts | Closest UK SME direct peer |
Schroders Capital Global Innovation Trust | INOV | Sister Schroders vehicle in private/public innovation | Has undergone tender-offer capital returns in 2025 |
Molten Ventures | GROW | European venture/growth | Earlier stage, higher risk |
Chrysalis Investments | CHRY | Late-stage growth | Concentrated growth, capital-return programme |
Augmentum Fintech | AUGM | UK/European fintech | Venture/growth fintech |
Competitor Detail
| Metric | SBO |
|---|---|
NAV (GBP Mn, latest) | 79.2 |
NAV TR latest FY (%) | -3.0 |
Discount (%) | 34.7 |
OCR (%) | 1.29 |



